Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety
Schlichtig K, Duerr P, Dörje F, Fromm F (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: SPRINGER HEIDELBERG
City/Town: HEIDELBERG
Pages Range: S18-S18
Conference Proceedings Title: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Event location: Stockholm
Authors with CRIS profile
Katja Schlichtig
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Frank Dörje
Professur für Molekulare und Klinische Pharmazie
How to cite
APA:
Schlichtig, K., Duerr, P., Dörje, F., & Fromm, F. (2019). Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (pp. S18-S18). Stockholm, SE: HEIDELBERG: SPRINGER HEIDELBERG.
MLA:
Schlichtig, Katja, et al. "Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety." Proceedings of the 14th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics (EACPT), Stockholm HEIDELBERG: SPRINGER HEIDELBERG, 2019. S18-S18.
BibTeX: Download